Gene · 4277
Papers3,381
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
881 to 900 of 3,381
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Phenotypic and Functional Plasticity of CXCR6+ Peripheral Blood NK Cells. | Front Immunol | 2021 | 35173710 | PubTator, text mining | PubMed |
| Insights Into the Emergence of Paroxysmal Nocturnal Hemoglobinuria. | Front Immunol | 2021 | 35154088 | PubTator, text mining | PubMed |
| Comprehensive Landscape of Immune Infiltration and Aberrant Pathway Activation in Ischemic Stroke. | Front Immunol | 2021 | 35140708 | PubTator, text mining | PubMed |
| Construction of a novel ceRNA network and identification of lncRNA ADAMTS9-AS2 and PVT1 as hub regulators of miRNA and coding gene expression in gastric cancer. | Transl Cancer Res | 2021 | 35116422 | PubTator, text mining | PubMed |
| The Role of miRNA in Tumor Immune Escape and miRNA-Based Therapeutic Strategies. | Front Immunol | 2021 | 35116035 | PubTator, text mining | PubMed |
| Natural Killer Cells in Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis - A Review of the Literature. | Front Immunol | 2021 | 35116030 | PubTator, text mining | PubMed |
| Prognostic Value and Immunological Role of KIFC1 in Hepatocellular Carcinoma. | Front Mol Biosci | 2021 | 35111813 | PubTator, text mining | PubMed |
| Tumor-Infiltrating Lymphocytes in Colorectal Cancer: The Fundamental Indication and Application on Immunotherapy. | Front Immunol | 2021 | 35095898 | PubTator, text mining | PubMed |
| Natural Killer Cells in the Malignant Niche of Multiple Myeloma. | Front Immunol | 2021 | 35087536 | PubTator, text mining | PubMed |
| Back to the Future: Spatiotemporal Determinants of NK Cell Antitumor Function. | Front Immunol | 2021 | 35082797 | PubTator, text mining | PubMed |
| A Linear Discriminant Analysis Model Based on the Changes of 7 Proteins in Plasma Predicts Response to Anlotinib Therapy in Advanced Non-Small Cell Lung Cancer Patients. | Front Oncol | 2021 | 35070967 | PubTator, text mining | PubMed |
| Filamin A Is Required for NK Cell Cytotoxicity at the Expense of Cytokine Production via Synaptic Filamentous Actin Modulation. | Front Immunol | 2021 | 35058930 | PubTator, text mining | PubMed |
| Natural Receptor- and Ligand-Based Chimeric Antigen Receptors: Strategies Using Natural Ligands and Receptors for Targeted Cell Killing. | Cells | 2021 | 35011583 | PubTator, text mining | PubMed |
| Challenges and Recent Advances in NK Cell-Targeted Immunotherapies in Solid Tumors. | Int J Mol Sci | 2021 | 35008589 | PubTator, text mining | PubMed |
| Importance of T, NK, CAR T and CAR NK Cell Metabolic Fitness for Effective Anti-Cancer Therapy: A Continuous Learning Process Allowing the Optimization of T, NK and CAR-Based Anti-Cancer Therapies. | Cancers (Basel) | 2021 | 35008348 | PubTator, text mining | PubMed |
| General Features and Novel Gene Signatures That Identify Epstein-Barr Virus-Associated Epithelial Cancers. | Cancers (Basel) | 2021 | 35008199 | PubTator, text mining | PubMed |
| Construction and Clinical Translation of Causal Pan-Cancer Gene Score Across Cancer Types. | Front Genet | 2021 | 35003220 | PubTator, text mining | PubMed |
| Intra- and Extracellular Effector Vesicles From Human T And NK Cells: Same-Same, but Different? | Front Immunol | 2021 | 35003134 | PubTator, text mining | PubMed |
| Saliva and Serum Cytokine Profiles During Oral Ulceration in Behçet's Disease. | Front Immunol | 2021 | 35003055 | PubTator, text mining | PubMed |
| Cytochrome b561 Serves as a Potential Prognostic Biomarker and Target for Breast Cancer. | Int J Gen Med | 2021 | 35002301 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4277/papers?page=45